Last updated: 17 July 2019 at 1:06pm EST

Kevin Krenitsky Net Worth




The estimated Net Worth of Kevin Krenitsky is at least $57.8 Тысяча dollars as of 19 May 2016. Kevin Krenitsky owns over 43,716 units of Enzo Biochem stock worth over $57,776 and over the last 15 years Kevin sold ENZ stock worth over $0.

Kevin Krenitsky ENZ stock SEC Form 4 insiders trading

Kevin has made over 1 trades of the Enzo Biochem stock since 2016, according to the Form 4 filled with the SEC. Most recently Kevin bought 43,716 units of ENZ stock worth $48,525 on 19 May 2016.

The largest trade Kevin's ever made was buying 43,716 units of Enzo Biochem stock on 19 May 2016 worth over $48,525. On average, Kevin trades about 5,465 units every 0 days since 2009. As of 19 May 2016 Kevin still owns at least 52,050 units of Enzo Biochem stock.

You can see the complete history of Kevin Krenitsky stock trades at the bottom of the page.



What's Kevin Krenitsky's mailing address?

Kevin's mailing address filed with the SEC is C/O OPGEN, INC., 708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG, MD, 20878.

Insiders trading at Enzo Biochem

Over the last 22 years, insiders at Enzo Biochem have traded over $2,615,763 worth of Enzo Biochem stock and bought 1,070,494 units worth $3,103,461 . The most active insiders traders include Bradley Louis Radoff, Management Corp Harbert Dis... и Elazar Rabbani. On average, Enzo Biochem executives and independent directors trade stock every 127 days with the average trade being worth of $59,099. The most recent stock trade was executed by Kara Cannon on 21 February 2024, trading 10,640 units of ENZ stock currently worth $11,810.



What does Enzo Biochem do?

enzo biochem inc is a financial services company located in 60 executive blvd, farmingdale, new york, united states.



Complete history of Kevin Krenitsky stock trades at Opgen Inc и Enzo Biochem

инсайдер
Транзакция
Транзакция
Общая стоимость
Kevin Krenitsky
Президент
Купить $5,464,500,000
19 May 2016


Enzo Biochem executives and stock owners

Enzo Biochem executives and other stock owners filed with the SEC include: